Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Effect of Btk inhibitor PCI-32765 monotherapy on responses in patients with relapsed aggressive NHL: Evidence of antitumor activity from a phase I study
Effect of Btk inhibitor PCI-32765 monotherapy on responses in patients with relapsed aggressive NHL: Evidence of antitumor activity from a phase I study Advani, R., Sharman, J. P., Smith, S. M., Pollyea, D. A., Boyd, T. E., Grant, B. W., Kolibaba, K. S., Buggy, J. J., Hamdy, A., Fowler, N. H. AMER SOC CLINICAL ONCOLOGY. 2010View details for DOI 10.1200/jco.2010.28.15_suppl.8012
View details for Web of Science ID 000208852005032